SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000792977-19-000131
Filing Date
2019-10-30
Accepted
2019-10-30 07:46:39
Documents
17
Period of Report
2019-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amag8-k102919.htm   iXBRL 8-K 40189
2 EXHIBIT 99.1 ex991.htm EX-99.1 17300
8 amag_rgb.jpg GRAPHIC 151973
9 ex991image1a09.gif GRAPHIC 2307
  Complete submission text file 0000792977-19-000131.txt   553308

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20191029.xsd EX-101.SCH 4588
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20191029_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20191029_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20191029_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20191029_pre.xml EX-101.PRE 13580
11 EXTRACTED XBRL INSTANCE DOCUMENT amag8-k102919_htm.xml XML 4356
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 191177853
SIC: 2834 Pharmaceutical Preparations